BioSyent (RX) Insider Trading & Ownership

C$8.51
0.00 (0.00%)
(As of 04:29 PM ET)

BioSyent (CVE:RX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
38.24%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
C$8,700.00
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
C$13,720.00
Get RX Insider Trade Alerts

Want to know when executives and insiders are buying or selling BioSyent stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RX Insider Buying and Selling by Quarter

BioSyent Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/28/2024Larry AndrewsDirectorBuy1,000C$8.70C$8,700.00
3/26/2024Peter Douglas LockhardDirectorSell600C$8.70C$5,220.00
11/27/2023Seyed Ahmad AshrafiDirectorSell1,000C$8.50C$8,500.00
(Data available from 1/1/2013 forward)

RX Insider Trading Activity - Frequently Asked Questions

Who is on BioSyent's Insider Roster?

The list of insiders at BioSyent includes Blair Driscoll, Larry Andrews, Peter Douglas Lockhard, Seyed Ahmad Ashrafi, and Sharan Raghubir. Learn more on insiders at RX.

What percentage of BioSyent stock is owned by insiders?

38.24% of BioSyent stock is owned by insiders. Learn more on RX's insider holdings.

Which BioSyent insiders have been buying company stock?

The following insiders have purchased RX shares in the last 24 months: Blair Driscoll (C$194,750.00), and Larry Andrews (C$8,700.00).

How much insider buying is happening at BioSyent?

Insiders have purchased a total of 26,000 RX shares in the last 24 months for a total of C$203,450.00 bought.

Which BioSyent insiders have been selling company stock?

The following insiders have sold RX shares in the last 24 months: Peter Douglas Lockhard (C$5,220.00), and Seyed Ahmad Ashrafi (C$8,500.00).

How much insider selling is happening at BioSyent?

Insiders have sold a total of 1,600 BioSyent shares in the last 24 months for a total of C$13,720.00 sold.


More Insider Trading Tools from MarketBeat

This page (CVE:RX) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners